July 14, 2022
Inexpensive, safe nasal drops could be produced to combat COVID-19 and other viral pandemics
November 11, 2021
The virtual event featured talks from Daria Mochly-Rosen and other SPARK scholars and advisors
October 4, 2021
SPARK GLOBAL regional representatives met virtually for the annual meeting
July 1, 2021
SPARK Scholar investigates a repurposed drug to prevent NASH, a disease with no approved treatments
May 27, 2021
Two first-year graduate students discuss their research into SARS-CoV-2 variants
April 23, 2021
Dr. Peter Santa Maria continues his SPARK journey to understand and treat chronic ear infection
March 24, 2021
SPARK staff lead an effort to characterize cardiovascular biomarkers of COVID-19 to better treat patients
February 10, 2021
Advisor participation is voluntary with no compensation. So what do advisors get out of the program? In their own words.
January 22, 2021
What is passive immunization, and why is the use of IgY antibodies from chickens in a preventative therapy so advantageous?
December 17, 2020
Preparing for a pandemic part 2: How nasal drops are easy and inexpensive to produce worldwide
December 9, 2020
Nasal drops technology could be a blueprint to combat a future outbreak
November 24, 2020
SPARK is developing a unique approach to fight coronavirus, but we need your help
October 14, 2020
Medicinal chemist and blogger Derek Lowe offers questions and suggestions on the state of drug discovery – how can we improve?
August 26, 2020
Stanford researchers review drug repurposing approaches that could be key to combating COVID-19
August 5, 2020
Dr. Russ Altman explores machine learning’s usefulness for predicting a gene’s effect on drug metabolism.